ResMed (RMD) Tops Q3 EPS by 25c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
ResMed (RMD:AU) (RMD) PT Raised to AUD22.60 at JPMorgan
April 28, 2020 1:13 PM EDTJPMorgan raised its price target on ResMed (RMD:AU) to AUD22.60 (from AUD22.00) while maintaining a Neutral rating.
Analyst lowers price target on (NYSE: RMD) to US$145 from US$150. Maintains Neutral rating.
... More